ArticleBMC pulmonary medicine2026
Associated factors and predictive nomogram of long COVID: a cross-sectional study in China.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundLong COVID (coronavirus disease) poses a substantial challenge to individual and global public health. In the context of China’s Omicron wave, key aspects such as its long-impact on non-hospitalized adults, the role of reinfection and other pathogenic infections during recovery require updated evidence. Therefore, the aim of this study is to delineate factors associated with long COVID and create a robust predictive model for primary-care to identify individuals at high risk of long COVID, utilizing data collected during the Omicron wave.
methodsThis study employed an online survey to assess SARS-CoV-2 infection status and track long COVID symptoms 9 to 15 months post-initial infection in 2099 participants. Associated factors of long COVID were identified through univariable and multivariable logistic regression analyses. The long COVID risk prediction model was visualized using a nomogram, and its performance was evaluated using the area under the curve (AUC) and a calibration curve.
resultsAn analysis of 1,408 valid responses revealed that 35.9% of participants reported persistent long COVID symptoms 9 to 15 months after their initial SARS-CoV-2 infection. During the rehabilitation period, SARS-CoV-2 re-infection and other respiratory infections were reported in 32.4% and 34.3% of cases, respectively. The most prevalent long COVID symptoms were as follows: fatigue (16.2%), cough (9.0%), decreased activity tolerance (7.3%), shortness of breath (6.0%), expectoration (5.8%), and forgetfulness (5.7%). Multivariable analysis identified the factors independently associated with long COVID: female gender, absence of comorbidities, frequency of SARS-CoV-2 infections, history of other respiratory infections, and the presence of seven acute symptoms. Using logistic regression analysis, we developed a nomogram for long COVID prediction, which achieved an AUC of 0.731. Additional subgroup analysis revealed that participants with either SARS-CoV-2 reinfection or other pathogenic respiratory infections were more likely to report both a higher number of long COVID symptoms and increased symptom severity.
conclusionsIn summary, to mitigate the risk of long COVID, it is critical to prevent SARS-CoV-2 reinfection and other respiratory infections during the post-infection period. We developed a user-friendly nomogram model with satisfactory predictive performance to evaluate the risk of long COVID among COVID-19 patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.